Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Nerve Injuries | 2 | 2014 | 10 | 0.490 |
Why?
|
| Salivary Glands, Minor | 1 | 2015 | 10 | 0.480 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 55 | 0.470 |
Why?
|
| Methylprednisolone | 1 | 2014 | 91 | 0.440 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 98 | 0.430 |
Why?
|
| Optic Nerve | 2 | 2014 | 114 | 0.420 |
Why?
|
| Endoscopy | 2 | 2014 | 280 | 0.420 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 666 | 0.340 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1021 | 0.330 |
Why?
|
| Visual Acuity | 1 | 2014 | 817 | 0.320 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 130 | 0.280 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2019 | 163 | 0.270 |
Why?
|
| Gastrostomy | 2 | 2019 | 84 | 0.190 |
Why?
|
| Graves Ophthalmopathy | 1 | 2021 | 12 | 0.180 |
Why?
|
| Neuralgia | 1 | 2021 | 44 | 0.180 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 1248 | 0.160 |
Why?
|
| Laryngeal Neoplasms | 1 | 2019 | 80 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 1997 | 22 | 0.140 |
Why?
|
| Hyperparathyroidism | 1 | 1997 | 24 | 0.140 |
Why?
|
| Adenoma | 1 | 1997 | 129 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 523 | 0.120 |
Why?
|
| Ethmoid Bone | 1 | 2015 | 8 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 420 | 0.120 |
Why?
|
| Maxilla | 1 | 2015 | 36 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 144 | 0.120 |
Why?
|
| Recurrence | 3 | 2014 | 1420 | 0.110 |
Why?
|
| Middle Aged | 12 | 2019 | 26712 | 0.110 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 276 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 253 | 0.110 |
Why?
|
| Laryngeal Diseases | 2 | 2004 | 32 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 361 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 617 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2014 | 381 | 0.090 |
Why?
|
| Veterans | 2 | 2019 | 1755 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1690 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 5145 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 3443 | 0.080 |
Why?
|
| Nose Neoplasms | 1 | 1990 | 32 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 1990 | 44 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1139 | 0.080 |
Why?
|
| Zenker Diverticulum | 1 | 2008 | 4 | 0.080 |
Why?
|
| Orbit | 2 | 2021 | 102 | 0.080 |
Why?
|
| Male | 13 | 2019 | 61194 | 0.080 |
Why?
|
| Skull Neoplasms | 1 | 1988 | 14 | 0.070 |
Why?
|
| Mandibular Diseases | 1 | 1987 | 9 | 0.070 |
Why?
|
| Esophagoscopy | 1 | 2008 | 156 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 2 | 2002 | 490 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2021 | 16312 | 0.070 |
Why?
|
| Aged | 8 | 2019 | 19700 | 0.060 |
Why?
|
| Humans | 18 | 2021 | 124592 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 1988 | 190 | 0.060 |
Why?
|
| Female | 13 | 2019 | 66483 | 0.060 |
Why?
|
| Osteomyelitis | 1 | 1987 | 205 | 0.060 |
Why?
|
| Time Factors | 2 | 2014 | 6293 | 0.060 |
Why?
|
| Laryngectomy | 1 | 2004 | 25 | 0.060 |
Why?
|
| Aspergillosis | 1 | 2004 | 43 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 1987 | 309 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 1232 | 0.050 |
Why?
|
| Abscess | 1 | 2004 | 138 | 0.050 |
Why?
|
| Xerostomia | 1 | 2002 | 8 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2014 | 12324 | 0.050 |
Why?
|
| Pharyngeal Diseases | 1 | 2003 | 19 | 0.050 |
Why?
|
| Radiotherapy, Conformal | 1 | 2002 | 55 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 293 | 0.050 |
Why?
|
| Anti-Ulcer Agents | 1 | 2003 | 110 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 127 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2002 | 143 | 0.050 |
Why?
|
| Laryngoscopy | 1 | 2003 | 151 | 0.040 |
Why?
|
| Glottis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Deglutition | 1 | 2019 | 48 | 0.040 |
Why?
|
| Sinusitis | 1 | 2000 | 116 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 247 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2000 | 2090 | 0.040 |
Why?
|
| Adult | 5 | 2014 | 29435 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 869 | 0.030 |
Why?
|
| Sphenoid Bone | 1 | 1997 | 10 | 0.030 |
Why?
|
| Cysts | 1 | 1997 | 101 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 6533 | 0.030 |
Why?
|
| Prognosis | 3 | 2019 | 4624 | 0.030 |
Why?
|
| Nose | 1 | 1997 | 93 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1997 | 197 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2044 | 0.030 |
Why?
|
| United States | 2 | 2019 | 10887 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 1136 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3138 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 1660 | 0.020 |
Why?
|
| Risk Factors | 2 | 2019 | 10265 | 0.020 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1990 | 17 | 0.020 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1989 | 12 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 1990 | 50 | 0.020 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1989 | 57 | 0.020 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2008 | 4 | 0.020 |
Why?
|
| Propionibacterium acnes | 1 | 1987 | 12 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1988 | 100 | 0.020 |
Why?
|
| Angiography | 1 | 1988 | 215 | 0.020 |
Why?
|
| Mandible | 1 | 1987 | 79 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 832 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 24 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 2004 | 64 | 0.010 |
Why?
|
| Parotid Gland | 1 | 2002 | 20 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2008 | 3064 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2002 | 183 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2004 | 288 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 323 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 575 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 299 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 429 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1990 | 3554 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 711 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2003 | 6135 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 647 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 2000 | 25 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 295 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2049 | 0.010 |
Why?
|
| Sphenoid Sinus | 1 | 1997 | 12 | 0.010 |
Why?
|
| Turbinates | 1 | 1997 | 12 | 0.010 |
Why?
|
| Endoscopes | 1 | 1997 | 20 | 0.010 |
Why?
|
| Nerve Compression Syndromes | 1 | 1997 | 22 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 1997 | 36 | 0.010 |
Why?
|
| Skull Fractures | 1 | 1997 | 43 | 0.010 |
Why?
|
| Craniotomy | 1 | 1997 | 108 | 0.010 |
Why?
|
| Adolescent | 3 | 2004 | 19275 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 154 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1184 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3280 | 0.010 |
Why?
|
| Optic Nerve Diseases | 1 | 1997 | 88 | 0.010 |
Why?
|
| Lacrimal Apparatus | 1 | 1997 | 122 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1997 | 211 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1997 | 317 | 0.010 |
Why?
|
| Quality of Life | 1 | 2002 | 1915 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2002 | 3693 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1989 | 51 | 0.010 |
Why?
|
| Child | 1 | 1989 | 24367 | 0.000 |
Why?
|